Constraint-Induced Movement Therapy for Adults Post-Stroke With Mild Upper Extremity Impairment
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT05492513
- Status
- Recruiting
Conditions
- CVA (Cerebrovascular Accident)
- Stroke
- Upper Extremity Paresis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Grade 1 CI Therapy +Sensory Components — BEHAVIORALAll participants will receive Grade 1 CI Therapy + Sensory Components over a two-week period of time. The treatment intervention will include all CI Therapy treatment strategies including: 1) supervised motor training in the form of shaping with repeated trials and task practice for 1.5 hours per day for 5 weekdays for 2 weeks 2) a behavioral Transfer Package (TP) will be employed to aid carry-over of skills gained by the participant in the laboratory to the life situation 3) each participant will wear a mitt on the less-affected hand for most of their waking hours to encourage use of the more-affected hand 4) participants will be given home assignments to be carried out for at least 30 minutes each day. Sensory component strategies will be added to stimulate sensory input through the more-affected arm and hand as well as to train sensory discrimination skills.
Study Details
Constraint-Induced Therapy (CI Therapy) is a behavioral approach to neurorehabilitation and consists of multi-components that have been applied in a systematic method to improve the use of the limb or function addressed in the intensive treatment. CI Therapy for the more-affected upper extremity (UE) post-stroke is administered in daily treatment sessions over consecutive weekdays. Sessions include motor training with repeated, timed trials using a technique called shaping, a set of behavioral strategies known as the Transfer Package (TP) to improve the use of the more-affected hand in the life situation, and strategies to remind participants to use the more-affected UE including restraint. Robust improvements in the amount and qualify of use have been realized with stroke participants from mild-to-severe UE impairment.
Key Dates
- Start date
- Dec 8, 2022
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Grade 1 CI Therapy + Sensory ComponentsAll participants will receive the Grade 1 CI Therapy + Sensory Components administered over a two-week period of time.
Primary Outcome Measure
45-Item Motor Activity Log (MAL) [ Time Frame: At post treatment after 2 weeks of intervention ]
Central Contacts
- Mary H Bowman, BS OT2059340069
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 |
Find similar trials in Birmingham, AL
Related Studies
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)PHASE2/PHASE3 · Recruiting · DiaMedica Therapeutics Inc · Fairhope, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsRecruiting · University of Cincinnati · Birmingham, Alabama